Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
X Financial A ADR | XYF | Oct 30, 2024 | 6.49 | -1.07 |
X3 Holdings | XTKG | Oct 30, 2024 | 0.12 | -7.70 |
X4 Pharmaceuticals | XFOR | Oct 30, 2024 | 0.52 | +4.32 |
XAI Octagon Floating Rate & Alternative Income Term Trust | XFLT | Oct 30, 2024 | 6.92 | +0.44 |
XAI Octagon Floating Rate & Alternative Income Term Trust 20 | XFLT-A | Oct 30, 2024 | 25.03 | +0.20 |
XBiotech | XBIT | Oct 30, 2024 | 7.39 | +3.28 |
XBP Europe | XBP | Oct 30, 2024 | 1.07 | +2.88 |
Xcel Brands | XELB | Oct 30, 2024 | 0.79 | -1.84 |
Xcel Energy | XEL | Oct 30, 2024 | 63.05 | -0.46 |
XChange Tec.Inc ADR | XHG | Oct 30, 2024 | 0.18 | -4.55 |
XCHG Limited - ADS | XCH | Oct 30, 2024 | 19.55 | 0.00 |
Xencor | XNCR | Oct 30, 2024 | 21.02 | -2.55 |
Xenetic Biosciences | XBIO | Oct 30, 2024 | 4.28 | +15.36 |
Xenia Hotels & Resorts | XHR | Oct 30, 2024 | 14.66 | +0.34 |
Xenon Pharmaceuticals | XENE | Oct 30, 2024 | 41.89 | +0.26 |
Xeris Biopharma | XERS | Oct 30, 2024 | 3.23 | 0.00 |
Xerox | XRX | Oct 30, 2024 | 8.23 | -3.06 |
XIAO-I ADR | AIXI | Oct 30, 2024 | 4.44 | -0.22 |
Xilio Therapeutics | XLO | Oct 30, 2024 | 1.37 | +38.38 |
Xinyuan Real Estate ADR | XIN | Oct 30, 2024 | 3.92 | +1.82 |
XOMA | XOMA | Oct 30, 2024 | 29.86 | -6.48 |
XOMA A Pref | XOMAP | Oct 30, 2024 | 26.28 | -0.76 |
XOMA B Pref | XOMAO | Oct 30, 2024 | 25.60 | +0.16 |
Xometry A | XMTR | Oct 30, 2024 | 19.61 | -4.15 |
XORTX Therapeutics | XRTX | Oct 30, 2024 | 1.48 | -2.63 |
Xos | XOS | Oct 30, 2024 | 4.51 | -4.04 |
XP A | XP | Oct 30, 2024 | 17.90 | +0.79 |
XPEL | XPEL | Oct 30, 2024 | 40.02 | -2.46 |
XPeng A ADR | XPEV | Oct 30, 2024 | 11.35 | -2.16 |
Xperi | XPER | Oct 30, 2024 | 9.32 | -2.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.